US Stock MarketDetailed Quotes
PFE Pfizer
- 30.770
- +1.010+3.39%
Close Jul 26 16:00 ET
- 30.680
- -0.090-0.29%
Post 20:01 ET
174.36BMarket Cap-615400P/E (TTM)
30.880High30.010Low35.66MVolume30.150Open29.760Pre Close1.09BTurnover0.63%Turnover Ratio83.16P/E (Static)5.67BShares35.11452wk High1.89P/B174.11BFloat Cap24.48052wk Low1.65Dividend TTM5.66BShs Float54.716Historical High5.36%Div YieldTTM2.92%Amplitude5.477Historical Low30.625Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Pfizer Stock Forum
PFE us at resistance, 30.70
Earnings soon, stars aligned
above 50 EMA
When PFE turns, it will move hard and fast. a lot of pressure has been built up over the 1.5-year drop.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.
Sneaking on the radar on a red day.
No comment yet